Sign in Subscribe
Pharmaceutical industry

Signal Pharmaceuticals Appoints Carl F. Bobkoski as Executive Vice President

Strategic Insights

— 1 min read

Signal Pharmaceuticals Inc. has announced the appointment of Carl F. Bobkoski as executive vice president, bringing his expertise in biopharmaceutical industry leadership to the company. Bobkoski joins Signal from Gensia Inc., where he held the same position and was a member of the board of directors. His experience in directing commercialization activities, overseeing research operations, and supervising product development will benefit Signal's expanding research efforts.

Key Takeaways:

  • Carl F. Bobkoski was appointed as executive vice president at Signal Pharmaceuticals Inc. on August 9, 1995.
  • Bobkoski joins Signal from Gensia Inc., where he was executive vice president and a member of the board of directors.
  • At Gensia, Bobkoski was responsible for directing all commercialization activities, overseeing the operations of Gensia Laboratories, and supervising product development, finance, MIS, and corporate development.
  • Prior to joining Gensia, Bobkoski was president and CEO of GalenPharma, a neurology-based biopharmaceutical company he co-founded.
  • As executive vice president, Bobkoski is expected to play a key role in establishing research collaborations with pharmaceutical companies at Signal.
  • Signal Pharmaceuticals is pioneering the discovery and development of small molecule therapeutics that regulate the transcription factors involved in inflammatory, viral, and neurological diseases.
  • The company's core technology was discovered in the laboratories of its three founders and has been licensed from the University of California and The Salk Institute.

Statistics:

  • Signal Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of small molecule drugs.
  • The company was founded by three individuals and has licensed its core technology from the University of California and The Salk Institute.
  • Signal Pharmaceuticals is headquartered in San Diego, California.

Sources:

  • BARCLAYS GLOBAL INVESTORS is not mentioned but a public source publicly reported the information in 1995.
  • BUSINESS WIRE reported the announcement on August 9, 1995.

Read more